FRI0531 Drug Survival of Biological Therapy in Patients with Juvenile Idiopathic Arthritis: 10 Years Experience in a Single Center

BackgroundBiologic agents have improved the possibility of treatment of juvenile idiopathic arthritis (JIA). Infliximab has the longest history of using and despite of off-label status was administrated from 2004. Etanercept is available in Russia from 2009. Unfortunately some patients do not respon...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.620-621
Hauptverfasser:	Arsenyeva, S.V., Nikishina, I.P., Kaleda, M.I., Shapovalenko, A.N., Rodionovskaya, S.R., Fedorov, E.S., Alekseev, D.L., Medyntzeva, L.G.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!